Global stock markets extended their declines on Tuesday as concerns over lofty U.S. artificial intelligence valuations continued to weigh on investor sentiment.
The FTSE 100 fell 0.9% in early trading, mirroring weakness across Europe, where Germany’s DAX dropped 1.1% and France’s CAC 40 slid 1.3%.
U.S. index futures were also in negative territory, adding to the downbeat tone.
Despite the broader sell-off, some FTSE 100 constituents posted gains. ICG surged 9.1% after reporting robust growth, with assets under management rising to $124 billion.
Fee-earning AUM climbed 6% in the half year to $84 billion, with a five-year annualised growth rate of 14%.
The group also announced a long-term strategic partnership with Amundi aimed at expanding the development and distribution of private markets products for wealth investors.
Imperial Brands rose 2.4% as investors welcomed solid full-year results. Increased demand for smoking alternatives, including oral nicotine, and higher cigarette prices helped lift adjusted operating profit by 4.6%.
Revenues fell 0.7% to £32.2 billion, but grew 4.1% when stripping out duties and currency effects.
AstraZeneca added 1.8%, rounding out the morning’s top performers.
The mining sector dragged on the index, with Fresnillo down 6% and Anglo American off 4.1% amid renewed pressure on commodities. ConvaTec also fell sharply, dropping 3.9%.
The continued decline across major indices underscored mounting investor caution as the rally driven by AI-linked stocks shows signs of strain.
Searching for the Perfect Broker?
Discover our top-recommended brokers for trading or investing in financial markets. Dive in and test their capabilities with complimentary demo accounts today!
- Admiral Markets More than 4500 stocks & over 200 ETFs available to invest in – Read our Review
- Vantage High levels of account and deposit protection – Read our Review
- eToro Wide range of instruments available to trade – Read our Review
YOUR CAPITAL IS AT RISK. 76% OF RETAIL CFD ACCOUNTS LOSE MONEY